On 9 October 2026, Ghana took another important step towards strengthening its health response to drug dependence. The Ghana Health Service (GHS), through the National AIDS and STI Control Programme (NACP), and in collaboration with WAPCAS Plus, convened 35 representatives from state agencies and civil society to validate the country’s Rapid OAT Readiness Assessment, Supply Chain Engagement and National Roadmap Development.
The readiness assessment, validated by key stakeholders, examined Ghana’s preparedness to introduce Opioid Agonist Treatment (OAT). The findings point to important foundations across policy, health-system capacity and community readiness, while also identifying areas requiring further attention, including specialised training, regulatory and supply arrangements, psychosocial support and sustainable financing.
Encouragingly, the assessment indicates strong community acceptance and reinforces the importance of involving affected communities in the design and implementation of services. It recommends beginning with a carefully controlled initial phase in specialised, prepared facilities, with expansion informed by experience and lessons learned.
OAT should not be viewed as a standalone intervention. Its effectiveness depends on being embedded within a broader continuum of medical care, psychosocial support, HIV and other health services, and social support.
For ADPLEO, this is ultimately about moving from evidence to practice: ensuring that policy decisions are grounded in research, responsive to the needs of people and communities, and capable of delivering better health and safer communities.
The opportunity is clear: with thoughtful implementation, sustainable investment and meaningful community participation, a healthier and safer Ghana is within reach.